A
Andreas Herrmann
Researcher at Humboldt University of Berlin
Publications - 371
Citations - 13813
Andreas Herrmann is an academic researcher from Humboldt University of Berlin. The author has contributed to research in topics: Membrane & Lipid bilayer fusion. The author has an hindex of 62, co-authored 369 publications receiving 12507 citations. Previous affiliations of Andreas Herrmann include Humboldt State University & Charité.
Papers
More filters
Journal ArticleDOI
High‐Fidelity Protein Targeting into Membrane Lipid Microdomains in Living Cells
Oliver Beutel,Jörg Nikolaus,Oliver Birkholz,Changjiang You,Thomas Schmidt,Andreas Herrmann,Jacob Piehler +6 more
TL;DR: Robust partitioning into lo phases was confirmed by using viral lipid mixtures and giant plasma membrane vesicles, and efficient protein targeting into lo and ld domains within the plasma membrane of living cells was demonstrated by single-molecule tracking, thus establishing a highly generic approach for exploring lipid microdomains in Situ.
Journal ArticleDOI
Parameters Influencing the Release of Tertiary Alcohols from the Surface of Spherical Dendrimers and Linear Stylomers by Neighbouring-Group-Assisted Hydrolysis of 2-Carbamoylbenzoates
TL;DR: An understanding of the physico-chemical parameters determining the local environment of the covalent-bond cleavage site is an important prerequisite to transfer the characteristics of small molecules to larger structures such as oligomers and polymers and thus to design efficient macromolecular conjugates for the controlled delivery of bioactive compounds.
Journal ArticleDOI
Conformational changes of the bacterial type I ATP-binding cassette importer HisQMP2 at distinct steps of the catalytic cycle.
Johanna Heuveling,Violette Frochaux,Joanna Ziomkowska,Robert Wawrzinek,Pablo Wessig,Andreas Herrmann,Erwin Schneider +6 more
TL;DR: Together, the data suggest similar conformational changes during the transport cycle as described for the maltose ABC transporter of Escherichia coli, despite distinct structural differences between both systems.
Journal ArticleDOI
RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals.
Markus Lesch,Madlen Luckner,Michael Meyer,Friderike Weege,Isabella Gravenstein,Martin Raftery,Christian Sieben,Laura Martin-Sancho,Aki Imai-Matsushima,Robert-William Welke,Rebecca Frise,Wendy S. Barclay,Günther Schönrich,Andreas Herrmann,Thomas F. Meyer,Alexander Karlas +15 more
TL;DR: Taken together, the otherwise clinically approved UBKIs regorafenib and sorafenIB possess high and broad-spectrum antiviral activity along with substantial robustness against resistance development and thus constitute attractive host-directed drug candidates against a range of viral infections including influenza.
Journal ArticleDOI
Plasma membrane asymmetry of lipid organization: fluorescence lifetime microscopy and correlation spectroscopy analysis
TL;DR: The results show that the combination of FLIM and ITIR-FCS with specific fluorescent lipid analogs is a powerful tool for investigating lateral and transbilayer characteristics of plasma membrane in live cell lines.